A randomized controlled trial evaluating pretest cancer genetics educational video or in-person genetic counseling.

Authors

Yanin Chavarri Guerra

Yanin Chavarri Guerra

Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, DF, Mexico

Yanin Chavarri Guerra , Andrea Morales Alfaro , Cesar Alcacio Vzquez , Araceli Carrillo Bedoya , Jazmin Arteaga , Jose Carlos Peñafort Zamora , Sofía Sánchez-Román , Daniela Ramirez Maza , Cynthia Villarreal-Garza , Nancy Reynoso , Alejandro Mohar , Juan Jose Calva Mercado

Organizations

Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, DF, Mexico, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, DF, Mexico, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, DF, Mexico, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico, Salvador Zubirán National Institute of Health Sciences and Nutrition, Mexico City, Mexico, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, Hospital Zambrano Hellion - Tecnologico de Monterrey, San Pedro Garza Garcia, Nuevo Leon, DF, Mexico, Instituto Nacional de Cancerologia, Mexico City, DF, Mexico, Instituto Nacional de Cancerologia, Mexico City, Mexico

Research Funding

No funding received
None.

Background: Cancer genetic testing indications are rapidly expanding to determine treatment eligibility for patients with cancer, to identify individual cancer risk as well as to select family members at higher cancer risk when a pathogenic variant (PV) has been identified in the family. Currently, international guidelines recommend that all candidates for genetic testing should have genetic counseling to make an informed decision for genetic testing. However, with the increased demand for genetic testing, innovative ways to deliver pretest information are needed, especially in limited resource settings, where genetic cancer professionals’ availability is scarce. Methods: This is a non-inferiority trial comparing a pretest educational video to in-person genetic counseling. Participants referred for genetic cancer risk assessment at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City were enrolled if they met international cancer genetic testing criteria and did not previously have genetic testing and/or counseling. The primary outcome was the uptake of genetic testing. Secondary outcomes included changes in genetic cancer knowledge, anxiety, and satisfaction using validated tools. Results: A total of 250 participants were included: 124 were randomized to the in-person genetic counseling arm and 126 to the educational video arm. Mean age was 47.9 years (SD 12.7), 86.4% were women, 37.2% had high-school or less and 86.4% had personal history of cancer (70% breast cancer). Overall, test acceptance was 100% in both arms. Cancer genetics knowledge improved in both groups: in-person from. 53 to .74 (diff .20; 95%CI .24-.26; p < 0.05) and video from .51 to .68 (diff .16; 95%CI .20-.12; p < 0.05). However, the in-person arm had a higher post counseling knowledge score (p 0.001). 43.5% and 42% of participants in the in-person and video arms had moderate-severe baseline anxiety. After intervention, both groups had a decrease in anxiety score: in-person from 5.2 to 4.7 (diff .58; 95% CI .09-1.08; p 0.01) and video from 4.9 to 4.1 (diff .75; 95%CI 0.42-1.08; p < 0.05). Both groups were satisfied with genetic services (97.5% and 92.5%, respectively; p 0.34). Conclusions: A pretest educational video was non-inferior regarding genetic testing acceptance. It was also associated with improved genetic cancer knowledge and decreased anxiety levels. These results support the use of educational videos before genetic testing where in-person genetic counseling availability is limited. Clinical trial information: pending.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Prevention, Risk Reduction, and Hereditary Cancer

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Germline Genetic Testing

Clinical Trial Registration Number

pending

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 10597)

DOI

10.1200/JCO.2023.41.16_suppl.10597

Abstract #

10597

Poster Bd #

230

Abstract Disclosures

Similar Abstracts

First Author: Steven Katz

First Author: Nicole Casasanta

First Author: Sourat Darabi

Abstract

2023 ASCO Genitourinary Cancers Symposium

Awareness of genetic risk for prostate cancer (PCa) in men from families with germline mutations in DNA-repair genes.

First Author: Massimo Lazzeri